KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to -$322.0 million.

  • Elevance Health's Deferred Taxes fell 17758.62% to -$322.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$279.0 million, marking a year-over-year increase of 2540.11%. This contributed to the annual value of -$279.0 million for FY2025, which is 2540.11% up from last year.
  • Elevance Health's Deferred Taxes amounted to -$322.0 million in Q4 2025, which was down 17758.62% from $269.0 million recorded in Q3 2025.
  • Elevance Health's Deferred Taxes' 5-year high stood at $269.0 million during Q3 2025, with a 5-year trough of -$322.0 million in Q4 2025.
  • For the 5-year period, Elevance Health's Deferred Taxes averaged around -$51.4 million, with its median value being -$68.5 million (2022).
  • As far as peak fluctuations go, Elevance Health's Deferred Taxes tumbled by 140000.0% in 2021, and later surged by 170000.0% in 2023.
  • Over the past 5 years, Elevance Health's Deferred Taxes (Quarter) stood at $228.0 million in 2021, then plummeted by 70.18% to $68.0 million in 2022, then tumbled by 454.41% to -$241.0 million in 2023, then soared by 51.87% to -$116.0 million in 2024, then plummeted by 177.59% to -$322.0 million in 2025.
  • Its Deferred Taxes was -$322.0 million in Q4 2025, compared to $269.0 million in Q3 2025 and -$52.0 million in Q2 2025.